share_log

MusclePharm (OTCMKTS:MSLP) Share Price Crosses Below 200 Day Moving Average of $0.16

MusclePharm (OTCMKTS:MSLP) Share Price Crosses Below 200 Day Moving Average of $0.16

MusclePharm(OTCMKTS: MSLP)股价跌破200日移动平均线0.16美元
Defense World ·  2022/12/09 03:42

MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.16 and traded as low as $0.01. MusclePharm shares last traded at $0.01, with a volume of 145 shares.

在周四的交易中,MusclePharmCo.的股价跌破了200日移动均线,200日移动均线切入位为0.16美元,最低交易价格为0.01美元。MusclePharm股价最新报0.01美元,成交量为145股。

MusclePharm Stock Performance

MusclePharm股票表现

The business has a fifty day simple moving average of $0.11 and a 200 day simple moving average of $0.16. The company has a market cap of $206,993.20, a P/E ratio of -0.01 and a beta of -0.07.

该业务的50日简单移动均线切入位为0.11美元,200日简单移动均线切入位为0.16美元。该公司市值为206,993.20美元,市盈率为-0.01,贝塔系数为-0.07。

MusclePharm Company Profile

MusclePharm公司简介

(Get Rating)

(获取评级)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.

公司在美国和国际上开发、制造、营销和分销运动营养品和营养补充剂。该公司提供一系列高性能粉末、胶囊、片剂、凝胶和随时可用的零食。该公司的MusclePharm品牌产品组合包括战斗蛋白粉和战斗挤压蛋白棒;以及支链氨基酸、肌酸、谷氨酰胺、肉碱、共轭亚油酸、鱼油、多种维生素和其他产品等基本补充剂。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
  • Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
  • This Is Why Daktronics Fell 40% In One Day
  • Is It Time To Throw In The Towel On Gamestop?
  • Why You Should Avoid Carvana Even if it Avoids Bankruptcy
  • Are Investors Hearing The End Of Spotify's Downtrend?
  • 免费获取StockNews.com关于MusclePharm的研究报告(MSLP)
  • 辉瑞、强生能否继续跑赢该指数?
  • 这就是为什么达科电子在一天内下跌了40%
  • 是时候在Gamestop上认输了吗?
  • 为什么你应该避免Carvana,即使它可以避免破产
  • 投资者是否听到了Spotify下跌趋势的终结?

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.

接受MusclePharm日报的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯收到对MusclePharm和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发